Clinical studies recruiting near Anaheim

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
Phase 3 · Advanced Research Center Inc. · Bristol-Myers Squibb · NCT06929273 A Study to Evaluate the Long-term Safety and Tolerability of KarXT and KarX-EC for the Treatment of Schizophrenia and Au
Phase 3 · Advanced Research Center Inc. · Karuna Therapeutics, Inc., a Bristol Myers Squibb company · NCT07424404 A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)
Phase 3 · Advanced Research Center Inc. · Bristol-Myers Squibb · NCT07288567 LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Phase 2 · Clinnova Research · Eli Lilly and Company · NCT07415044 A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
Phase 3 · Clinnova Research · Janssen Research & Development, LLC · NCT07499232 Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcera
Phase 3 · Smart Cures Clinical Research · Eli Lilly and Company · NCT06937086 Determining Efficacy and Safety of BXCL501 in Agitation Associated With Pediatric Schizophrenia and Bipolar Disorder
Phase 1 · BioXcel Clinical Research Site · BioXcel Therapeutics Inc · NCT05025605 A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymph
Phase 3 · Pacific Cancer Medical Center, Inc · Loxo Oncology, Inc. · NCT05254743 Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Phase 2/Phase 3 · Kaiser Permanente-Anaheim · NRG Oncology · NCT05174169 A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advance
Phase 3 · Research Site · AstraZeneca · NCT06692738 Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC Wi
Phase 3 · Research Site · AstraZeneca · NCT06357533 A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.
Phase 3 · Los Angeles Cancer Network (LACN) · Pfizer · NCT06629779 A Study to Evaluate the Safety, Tolerability, and Drug Levels of BMS-986521 in Healthy Participants.
Phase 1 · CenExel ACT (Formerly Anaheim Clinical Trials; LLC) · Bristol-Myers Squibb · NCT07283263 Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SL
Phase 3 · Kaiser Permanente-Anaheim · National Cancer Institute (NCI) · NCT04269902 Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and S
Phase 3 · Kaiser Permanente-Anaheim · Canadian Cancer Trials Group · NCT06592924 A Study to Learn About a Vaccine Against E Coli in Healthy Adults
Phase 1 · Anaheim Clinical Trials, LLC · Pfizer · NCT07122986 E-Mindfulness Approaches for Living After Breast Cancer
Phase 3 · Kaiser Permanente-Anaheim · NRG Oncology · NCT06748222 Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely
Phase 3 · Kaiser Permanente-Anaheim · NRG Oncology · NCT03180268 Evaluate the Pharmacokinetics, Safety, and Tolerability of NSHO-101 in Healthy Participants
Phase 1 · Cenexel Anaheim CA · Ensho Therapeutics, Inc. · NCT07403552 A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular
Phase 1 · Pacific Cancer Medical Center INC · Pfizer · NCT03460977 Study to Assess the Adverse Events of Oral ABBV-932 in Adult Participants With Depressive Episodes Associated With Bipol
Phase 2 · Advanced Research Center /ID# 273474 · AbbVie · NCT07220460 Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
Phase 3 · Advanced Research Center, Inc · Intra-Cellular Therapies, Inc. · NCT06372964 Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associate
Phase 3 · Advanced Research Center, Inc. · Karuna Therapeutics, Inc., a Bristol Myers Squibb company · NCT05980949 A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Dep
Phase 2 · Advanced Research Center /ID# 277537 · AbbVie · NCT07276997 Global Trial in APG2575 for Patients With CLL/SLL
Phase 3 · Ascentage Investigative Site · Ascentage Pharma Group Inc. · NCT06104566 A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Phase 1 · Providence Medical Foundation · Seagen, a wholly owned subsidiary of Pfizer · NCT04389632 Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
Phase 3 · Kaiser Permanente-Anaheim · Children's Oncology Group · NCT05235165 De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Eq
Phase 3 · Kaiser Permanente-Anaheim · NRG Oncology · NCT04852887 A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advance
Phase 3 · Research Site · AstraZeneca · NCT06627647 Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Ob
Phase 3 · Smart Cures Clinical Research · Eli Lilly and Company · NCT06937099

Look up another city

Look up another condition